CD36, CD41, CD61, and CD226 upregulated on LDNs associated with non-small-cell lung cancer (NSCLC) [23] and CD10, CD16, and CD45high present a mature phenotype with T cell-suppressive role in blood cancer [24]. Here, CD226 is linked to non-small cell lung carcinoma.